Online Inquiry
  •  

Anti-BTLA antibody Lentiviral Particle for Macrophage Engineering (MTS-0124-LX21)

Overview

Description
BTLA showed negative regulation for macrophage-related functions. The ready-to-use Anti-BTLA antibody Lentiviral Particle is packaged using 3rd generation of lentiviral packaging system, which is a research tool for macrophage cell engineering in vivo and in vitro.
Product Type
Virus Particles
Application Scenario
For in vivo and in vitro macrophage engineering

Target Specification

Engineering Approach
Checkpoint Antibody Seq Overexpression-Lentivirus
Species
Human
Target
Anti-BTLA antibody
Alternative Names
BTLA1; CD272
Full Name
B and T lymphocyte associated
Introduction
This gene encodes a member of the immunoglobulin superfamily. The encoded protein contains a single immunoglobulin (Ig) domain and is a receptor that relays inhibitory signals to suppress the immune response. Alternative splicing results in multiple transcript variants. Polymorphisms in this gene have been associated with an increased risk of rheumatoid arthritis.
UniprotID
GeneID
Applications
Resistant to reprogramming by tumor-secreted signals

Product Specification

Packaging System
Lentivirus
Titer
>1E8 TU/mL
Size
200uL; 1mL
Mycoplasma Testing
Negative
Sterility Testing
Negative
Shipping
Dry ice
Storage
Stored at -80°C for long term.
Handling Notes
Avoid multiple freeze/thaw cycles.
Restriction
RUO

For Research Use Only. Do Not Use in Food Manufacturing or Medical Procedures (Diagnostics or Therapeutics). Do Not Use in Humans.

CONTACT US
(USA)
(UK)
(Germany)
ADDRESS

> Global

ISO 9001 Certified - Creative Biolabs Quality Management System.

Copyright © 2024 Creative Biolabs. All Rights Reserved.